Background and Aims: Post-sternotomy pain management remains a key concern in adult cardiac surgery. This study evaluated the efficacy and safety of ropivacaine infiltration via a presternal multi-orifice catheter for postoperative analgesia. Design: A prospective randomized controlled trial. Setting: A single tertiary care center. Material and Methods: A total of 175 adult patients undergoing cardiac surgery via median sternotomy were randomized into three groups: Group A ( n = 58): Received 0.375% ropivacaine as continuous infusion at 5 mL/hour, Group B ( n = 58): Received 5 mL of 0.375% ropivacaine as intermittent boluses every 8 hours, and Group C ( n = 59): Received conventional intravenous tramadol. Pain was assessed using the visual analogue scale (VAS) for 48 hours post-extubation. Intravenous tramadol was used as rescue analgesia if VAS≥3. Results: Group B reported significantly lower VAS scores and rescue tramadol requirements (56 ± 35 mg) compared to Group A (155 ± 32 mg) and Group C (135 ± 45 mg). No significant differences were observed among the groups regarding hemodynamic parameters, catheter-related infections, time to extubation, or intensive care unit (ICU) stay. Conclusion: Presternal infiltration of 0.375% ropivacaine is safe and effective for post-sternotomy analgesia. The intermittent bolus technique provides superior pain relief and reduces opioid consumption compared to continuous infusion and standard intravenous analgesia.
Swetha et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: